Skip to main content
. Author manuscript; available in PMC: 2019 Mar 1.
Published in final edited form as: J Surg Oncol. 2017 Nov 28;117(4):756–764. doi: 10.1002/jso.24923

Table 4.

Benefits of Adjuvant Therapy by T stage*

OR (95% CI) P-value
T1
 Surgery alone 1 [Reference]
 Adj RT** 0.99 (0.68–1.44) 0.96
 Adj CRT** 2.03 (0.64–6.46) 0.23
T2
 Surgery alone 1 [Reference]
 Adj RT 0.62 (0.37–1.03) 0.07
 Adj CRT 0.75 (0.36–1.54) 0.44
T3
 Surgery alone 1 [Reference]
 Adj RT 0.68 (0.43–1.09) 0.11
 Adj CRT 0.56 (0.31–1.02) 0.06
T4a
 Surgery alone 1 [Reference]
 Adj RT 0.65 (0.45–0.93) 0.02
 Adj CRT 0.73 (0.49–1.08) 0.11
T4b
 Surgery alone 1 [Reference]
 Adj RT 0.68 (0.33–1.37) 0.28
 Adj CRT 0.47 (0.24–0.93) 0.03
*

When controlled for age, n stage, margin status, and comorbidity

**

OR, Odds Ratio; CI-Confidence Interval; Adj RT-Adjuvant Radiation Therapy; Adj CRT-Adjuvant Chemoradiation Therapy